Relationship between CA-125 and characteristics clinical and histopathological in epithelial ovarian cancer

被引:0
|
作者
Dolores-Velazquez, Rigoberto [1 ]
Patricia Bustamante-Montes, Lilia [2 ]
Roberto Romero-Fierro, Jose [1 ]
Gomez-Plata, Eduardo [1 ]
Gabriela Ocampo-Garcia, Karla [1 ]
Duenas-Gonzalez, Alfonso [3 ]
机构
[1] Ctr Oncol Estatal ISSEMyM, Coordinac Cirugia Oncol, Toluca, Mexico, Mexico
[2] Univ Autonoma Estado Mexico, Fac Med, Unidad Invest Enfoque Ecosistem, Toluca, Mexico, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed & Cancer, Mexico City, DF, Mexico
来源
GACETA MEXICANA DE ONCOLOGIA | 2014年 / 13卷 / 04期
关键词
CA-125; Ascites; Bilateral; Clinical stage; Differentiation grade; Histological type; Ovarian cancer; Mexico;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the clinical and histological features associated with CA-125 levels. Methods: The State Cancer Center records ISSEMyM 91 patients with diagnosis of epithelial ovarian cancer, of which CA-125 levels were obtained pretreatment, as well as the clinical and histological features of the tumor; values of CA-125 were log-normalized, analysis of variance, and t correlation test depending on the type of variable to be analyzed and inally a mult iple regression model was carried out, all of this was used to identify predictors was performed CA125 in the study population. Results: The presence of ascites, laterality, clinical stage, histological type and grade of differentiation show statistically signiicant associations with elevation of CA-125. We found that the number of pregnancies and the number of children was associated with increased CA-125 elevation, on the other hand, body mass index (BMI), tumor size and lymphovascular permeation showed no association with the elevation of this marker. The multiple regression model shows that the clinical stage, ascites, bilateral involvement, histologic type non-mucinous and poorly differentiated grade are the characteristics most CA-125 elevation. Conclusions: Clinical and histopathological, such as the presence of ascites, advanced clinical stage, bilaterality, differentiation grade and histological type are key features in the elevation of CA -125 determinants.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 50 条
  • [1] Is there a benefit to the lowest possible CA-125: The relationship between biomarkers and survival in epithelial ovarian cancer
    Clark, M.
    Al Houssan, L.
    Liu, Z.
    Bernardini, M. Q.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 261 - 261
  • [2] RELATIONSHIP BETWEEN SALIVA AND SERUM CA-125 IN WOMEN WITH AND WITHOUT EPITHELIAL OVARIAN-CANCER
    PLANTE, M
    WONG, GY
    NISSELBAUM, JS
    ALMADRONES, L
    HOSKINS, WJ
    RUBIN, SC
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (06): : 989 - 992
  • [3] CLINICAL IMPLICATIONS OF SERIAL CA-125 ESTIMATIONS IN EPITHELIAL OVARIAN-CANCER
    CRUICKSHANK, DJ
    TUMOR BIOLOGY, 1987, 8 (06) : 347 - 347
  • [4] CA-125 AUC as a predictor for epithelial ovarian cancer relapse
    Manoa, Antonio
    Falcao, Amilcar
    Godinho, Isabel
    Santos, Jorge
    Leitao, Fatima
    de Oliveira, Carlos
    Caramona, Margarida
    CANCER BIOMARKERS, 2008, 4 (02) : 73 - 81
  • [5] CA-125 as response criterion in patients with epithelial ovarian cancer
    Zirpel, I
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (04) : 200 - 200
  • [6] Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma
    Geisler, JP
    Miller, GA
    Lee, TH
    Harwood, RM
    Wiemann, MC
    Geisler, HE
    JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (03) : 140 - 142
  • [7] The relationship between ovarian volume and serum CA-125 levels
    Gulec, U. K.
    Paydas, S.
    Guzel, A. B.
    Vardar, M. A.
    Urunsak, I. F.
    Cetin, M. T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (03) : 280 - 283
  • [8] CA-125, A MARKER OF OVARIAN EPITHELIAL TUMORS
    RUIBAL, A
    MEDICINA CLINICA, 1988, 91 (02): : 54 - 57
  • [9] Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
    Lee, Juhun
    Kim, Jong Mi
    Lee, Yoon Hee
    Chong, Gun Oh
    Hong, Dae Gy
    ANTICANCER RESEARCH, 2022, 42 (01) : 349 - 353
  • [10] CA-125 AS A TUMOR-MARKER IN EPITHELIAL OVARIAN-CANCER
    SHEEHAN, JD
    DUFFY, MJ
    ALLEN, MA
    FENNELLY, JJ
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (01) : 10 - 13